弹性成像点定量与其他无创方法评估肝纤维化的比较
这项回顾性研究纳入406例接受肝活检的慢性肝病患者,其中361例获得ElastPQ和TE的肝硬度测量。ElastPQ值与纤维化分期相关(r=0.718;P<.001),诊断F≥2、F≥3和肝硬化的AUROC分别为0.856、0.951和0.965,最佳截断值分别为6.0 kPa、6.2 kPa和9.5 kPa。ElastPQ与TE诊断各期肝纤维化的准确性相当,均优于APRI和FIB-4。
要点
- ElastPQ诊断F≥2、F≥3和肝硬化的AUROC分别为0.856、0.951和0.965。
- ElastPQ分类F≥2、F≥3和肝硬化的最佳截断值分别为6.0 kPa、6.2 kPa和9.5 kPa,均低于TE。
- ElastPQ与TE对各期肝纤维化的诊断准确性相当,均优于APRI和FIB-4(P<.05)。
核心结论
- ElastPQ对慢性肝病患者肝纤维化的无创分期具有良好至优秀的性能。
- ElastPQ识别纤维化或肝硬化的准确性不劣于TE,且在识别各期肝纤维化方面优于血清纤维化指数。
研究设计与样本
- 回顾性研究,纳入2012年9月至2017年6月在意大利博洛尼亚一家门诊接受肝活检的406例任何病因的慢性肝病患者。
- 其中361例获得ElastPQ和TE的肝硬度测量,以肝活检为参考标准,采用METAVIR评分系统评估肝纤维化分期。
主要发现
- ElastPQ值与组织学检出的纤维化相关(r=0.718;P<.001)。
- ElastPQ检测显著纤维化(F≥2)的AUROC为0.856,检测进展期纤维化(F≥3)的AUROC为0.951,检测肝硬化的AUROC为0.965。
- ElastPQ分类F≥2、F≥3和肝硬化的最佳截断值分别为6.0 kPa、6.2 kPa和9.5 kPa,均低于TE的对应值。
- ElastPQ与TE在各期肝纤维化的诊断准确性比较结果相当。
- 两种弹性成像技术均优于APRI或FIB-4评分(所有AUROC比较P<.05)。
关键数值与推荐
- ElastPQ检测F≥2的AUROC为0.856,最佳截断值为6.0 kPa。
- ElastPQ检测F≥3的AUROC为0.951,最佳截断值为6.2 kPa。
- ElastPQ检测肝硬化的AUROC为0.965,最佳截断值为9.5 kPa。
临床怎么用
- 原文结论认为ElastPQ对慢性肝病患者肝纤维化的无创分期具有良好至优秀的性能。
- 原文结论认为ElastPQ识别纤维化或肝硬化的准确性不劣于TE,且在识别各期肝纤维化方面优于血清纤维化指数。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Elastography point quantification (ElastPQ) is a non-invasive method for assessing liver fibrosis based on liver stiffness. We evaluated the accuracy of ElastPQ for the staging of liver fibrosis in patients with chronic liver disease (CLD) compared with aspartate transaminase to platelet ratio index, fibrosis-4 index, and transient elastography (TE), using liver biopsy as reference standard. METHODS: We performed a retrospective study of 406 patients with CLD of any etiology who underwent liver biopsy analysis from September 2012 through June 2017 at a clinic in Bologna, Italy. We obtained liver stiffness measurements, made by ElastPQ and TE, for 361 patients. Liver fibrosis stage was assessed by the METAVIR scoring system. Areas under the receiver operating characteristic curve (AUROC) were used to assess the diagnostic performance of ElastPQ. RESULTS: ElastPQ values correlated with histologic detection of fibrosis (r = 0.718; P < .001). The AUROC values were 0.856 for detection of significant fibrosis (F≥2), 0.951 for advanced fibrosis (F≥3), and 0.965 for cirrhosis. The best cut-off values identified for classifying patients with F≥2, F≥3, or cirrhosis were 6.0 kPa, 6.2 kPa, and 9.5 kPa, respectively: these were lower than those for TE. Comparison of ElastPQ with TE data resulted in superimposable diagnostic accuracy of both methods for each stage of liver fibrosis. Both elastography techniques performed better than aspartate transaminase to platelet ratio index or fibrosis-4 index scores (P < .05 for all AUROC comparisons). CONCLUSIONS: ElastPQ has good to excellent performance for the non-invasive staging of liver fibrosis in patients with CLD. ElastPQ identified patients with fibrosis or cirrhosis with levels of accuracy that were not inferior to those of TE, and outperformed serum fibrosis indexes in identifying each stage of liver fibrosis.
引用
- Conti F, Serra C, Vukotic R, et al. Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods. Clin Gastroenterol Hepatol. 2018. PMID: 29935328. doi:10.1016/j.cgh.2018.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。